Clin2
NCT07281703Possibly a fitRecruiting

Safety study of HY8931 in healthy adults

Healthy

This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be between 18 and 45 years old.
  • You should be in good general health, without major medical conditions like heart, liver, or kidney disease.
  • Your body mass index (BMI) should be between 18 and 32, and you must weigh more than 110 pounds (50 kg).
  • You cannot have hepatitis B, C, HIV, or syphilis, and you must not have had a recent infection or fever.
  • You must not smoke more than 5 cigarettes a week, or drink more than 10–14 alcoholic drinks per week.
  • You cannot have taken any investigational drug or live vaccine in the last 90 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07262281Recruiting· Phase 1
Safety study of HY6725 in healthy adults

This trial tests a new drug called HY6725 in healthy volunteers to see if it is safe and how the body processes it. It may help pave the way for future treatments.

Melbourne
NCT06926218Not yet recruiting· Phase 1
Safety study of HSK47388 in healthy adults

This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.

Adelaide
NCT07566338Recruiting· Phase 1
Safety Study of LY4302814 in Healthy Adults

This is an early-stage study testing a new experimental medicine called LY4302814 in healthy volunteers to see if it is safe and how the body processes it. By enrolling healthy people first, researchers can understand the drug's basic safety profile before testing it in patients with medical conditions.

Daytona Beach, Florida
NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch
NCT07040046Recruiting· Phase 1
Study of HS-10542 in healthy volunteers

This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.

Qingdao, Shandong
NCT06716151Recruiting· Phase 1
HB0034 study for healthy Chinese adults

This trial tests a new medicine called HB0034 in healthy volunteers. It helps researchers understand how the drug works in the body before testing it in people with a medical condition.

Jinan, Shandong

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.